In vivo antidiabetic and ex-vivo antioxidant activities of dichloromethane extract of Xerophyta spekei

Abstract Background The medicinal plant Xerophyta spekei is used among Embu and Mbeere communities to manage diabetes mellitus. However, its efficacy has never been evaluated in vivo. The purpose of this study was to investigate its quantitative phytochemical and antidiabetic potential. Extraction w...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael Musila Ndile, Wycliffe Arika Makori, Cromwell Mwiti Kibiti, Mathew Piero Ngugi
Format: Article
Language:English
Published: SpringerOpen 2025-01-01
Series:Clinical Phytoscience
Subjects:
Online Access:https://doi.org/10.1186/s40816-024-00387-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594367477448704
author Michael Musila Ndile
Wycliffe Arika Makori
Cromwell Mwiti Kibiti
Mathew Piero Ngugi
author_facet Michael Musila Ndile
Wycliffe Arika Makori
Cromwell Mwiti Kibiti
Mathew Piero Ngugi
author_sort Michael Musila Ndile
collection DOAJ
description Abstract Background The medicinal plant Xerophyta spekei is used among Embu and Mbeere communities to manage diabetes mellitus. However, its efficacy has never been evaluated in vivo. The purpose of this study was to investigate its quantitative phytochemical and antidiabetic potential. Extraction was done using Dichloromethane (DCM). Quantitative phytochemical analysis was conducted using GC-MS. To evaluate antidiabetic activity, groups of mice which included normal control, diabetic control, positive control, and extract-administered groups (50, 100, 150, and 200 mg/kg body weight) were used. Alloxan monohydrate was used to induce diabetes. Blood glucose of the mice was determined hourly for the first six hours, and once after 12 and 24 h on the first day. Thereafter, the blood glucose in mice was determined once a week for three weeks. During the experimental period of three weeks, body weights were determined. After 21 days, lipid profiles, kidney and liver function tests as well as ex vivo antioxidant assays were carried out. Results The phytochemicals classes identified included flavonoids, phenolic compounds, phytosterols, terpenoids, fatty acids, tocopherols and alkaloids. Stigmasterol had the highest concentration (12.99 ± 2.56 mg/g). The extract decreased blood glucose dose-dependently, with 200 mg/kg bw dose resulting in the highest % mean change (40.10 ± 0.95). The extract gradually decreased blood glucose during 21 days of treatment. It attenuated loss of body weight and aberrant biochemical parameters including liver and renal function tests as well as lipid profiles in diabetic mice. Furthermore, it reduced levels of malondialdehyde and enhanced enzymatic antioxidant activities in diabetic mice. Conclusions The study confirms that DCM extract X. spekei contains phytochemicals with antioxidant and antidiabetic properties. The findings authenticate the folkloric use of X. spekei in managing diabetes mellitus. The medicinal plant also serves as a potential source for developing antidiabetic agents.
format Article
id doaj-art-c4818de5dfea419f89321e0a756b0855
institution Kabale University
issn 2199-1197
language English
publishDate 2025-01-01
publisher SpringerOpen
record_format Article
series Clinical Phytoscience
spelling doaj-art-c4818de5dfea419f89321e0a756b08552025-01-19T12:43:32ZengSpringerOpenClinical Phytoscience2199-11972025-01-0111111510.1186/s40816-024-00387-6In vivo antidiabetic and ex-vivo antioxidant activities of dichloromethane extract of Xerophyta spekeiMichael Musila Ndile0Wycliffe Arika Makori1Cromwell Mwiti Kibiti2Mathew Piero Ngugi3Department of Biochemistry, Microbiology and Biotechnology, Kenyatta UniversityDepartment of Biochemistry, Microbiology and Biotechnology, Kenyatta UniversityDepartment of Pure and Applied Sciences, Technical University of MombasaDepartment of Biochemistry, Microbiology and Biotechnology, Kenyatta UniversityAbstract Background The medicinal plant Xerophyta spekei is used among Embu and Mbeere communities to manage diabetes mellitus. However, its efficacy has never been evaluated in vivo. The purpose of this study was to investigate its quantitative phytochemical and antidiabetic potential. Extraction was done using Dichloromethane (DCM). Quantitative phytochemical analysis was conducted using GC-MS. To evaluate antidiabetic activity, groups of mice which included normal control, diabetic control, positive control, and extract-administered groups (50, 100, 150, and 200 mg/kg body weight) were used. Alloxan monohydrate was used to induce diabetes. Blood glucose of the mice was determined hourly for the first six hours, and once after 12 and 24 h on the first day. Thereafter, the blood glucose in mice was determined once a week for three weeks. During the experimental period of three weeks, body weights were determined. After 21 days, lipid profiles, kidney and liver function tests as well as ex vivo antioxidant assays were carried out. Results The phytochemicals classes identified included flavonoids, phenolic compounds, phytosterols, terpenoids, fatty acids, tocopherols and alkaloids. Stigmasterol had the highest concentration (12.99 ± 2.56 mg/g). The extract decreased blood glucose dose-dependently, with 200 mg/kg bw dose resulting in the highest % mean change (40.10 ± 0.95). The extract gradually decreased blood glucose during 21 days of treatment. It attenuated loss of body weight and aberrant biochemical parameters including liver and renal function tests as well as lipid profiles in diabetic mice. Furthermore, it reduced levels of malondialdehyde and enhanced enzymatic antioxidant activities in diabetic mice. Conclusions The study confirms that DCM extract X. spekei contains phytochemicals with antioxidant and antidiabetic properties. The findings authenticate the folkloric use of X. spekei in managing diabetes mellitus. The medicinal plant also serves as a potential source for developing antidiabetic agents.https://doi.org/10.1186/s40816-024-00387-6AntidiabetesAntioxidantDichloromethane extractXerophyta Spekei
spellingShingle Michael Musila Ndile
Wycliffe Arika Makori
Cromwell Mwiti Kibiti
Mathew Piero Ngugi
In vivo antidiabetic and ex-vivo antioxidant activities of dichloromethane extract of Xerophyta spekei
Clinical Phytoscience
Antidiabetes
Antioxidant
Dichloromethane extract
Xerophyta Spekei
title In vivo antidiabetic and ex-vivo antioxidant activities of dichloromethane extract of Xerophyta spekei
title_full In vivo antidiabetic and ex-vivo antioxidant activities of dichloromethane extract of Xerophyta spekei
title_fullStr In vivo antidiabetic and ex-vivo antioxidant activities of dichloromethane extract of Xerophyta spekei
title_full_unstemmed In vivo antidiabetic and ex-vivo antioxidant activities of dichloromethane extract of Xerophyta spekei
title_short In vivo antidiabetic and ex-vivo antioxidant activities of dichloromethane extract of Xerophyta spekei
title_sort in vivo antidiabetic and ex vivo antioxidant activities of dichloromethane extract of xerophyta spekei
topic Antidiabetes
Antioxidant
Dichloromethane extract
Xerophyta Spekei
url https://doi.org/10.1186/s40816-024-00387-6
work_keys_str_mv AT michaelmusilandile invivoantidiabeticandexvivoantioxidantactivitiesofdichloromethaneextractofxerophytaspekei
AT wycliffearikamakori invivoantidiabeticandexvivoantioxidantactivitiesofdichloromethaneextractofxerophytaspekei
AT cromwellmwitikibiti invivoantidiabeticandexvivoantioxidantactivitiesofdichloromethaneextractofxerophytaspekei
AT mathewpierongugi invivoantidiabeticandexvivoantioxidantactivitiesofdichloromethaneextractofxerophytaspekei